APA (7th ed.) Citation

Cooksley, W. G. E., Piratvisuth, T., Lee, S., Mahachai, V., Chao, Y., Tanwandee, T., . . . Pluck, N. (2003). Peginterferon α-2a (40 kDa): An advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. Journal of viral hepatitis, 10(4), 298-305. https://doi.org/10.1046/j.1365-2893.2003.00450.x

Chicago Style (17th ed.) Citation

Cooksley, W. G. E., et al. "Peginterferon α-2a (40 kDa): An Advance in the Treatment of Hepatitis B E Antigen-positive Chronic Hepatitis B." Journal of Viral Hepatitis 10, no. 4 (2003): 298-305. https://doi.org/10.1046/j.1365-2893.2003.00450.x.

MLA (9th ed.) Citation

Cooksley, W. G. E., et al. "Peginterferon α-2a (40 kDa): An Advance in the Treatment of Hepatitis B E Antigen-positive Chronic Hepatitis B." Journal of Viral Hepatitis, vol. 10, no. 4, 2003, pp. 298-305, https://doi.org/10.1046/j.1365-2893.2003.00450.x.